Publications of Dirk Bumann
All genres
Journal Article (37)
1.
Journal Article
8 (10), e1002966 (2012)
Immunity to Intracellular Salmonella Depends on Surface-associated Antigens. PLoS Pathogens 2.
Journal Article
7 (5), e35992 (2012)
Intestinal Inflammation Responds to Microbial Tissue Load Independent of Pathogen/Non-Pathogen Discrimination. PLoS ONE 3.
Journal Article
6 (6), e20749 (2011)
Salmonella-Induced Mucosal Lectin RegIII beta Kills Competing Gut Microbiota. PLoS ONE 4.
Journal Article
57 (8), pp. 1065 - 1072 (2008)
Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines. Gut 5.
Journal Article
37 (9), pp. 2370 - 2377 (2007)
Identification and isolation of murine antigen-reactive T cells according to CD154 expression. European Journal of Immunology 6.
Journal Article
440 (7082), pp. 303 - 307 (2006)
Robust Salmonella metabolism limits possibilities for new antimicrobials. Nature 7.
Journal Article
74 (3), pp. 1649 - 1660 (2006)
Salmonella enterica highly expressed genes are disease specific. Infection and Immunity 8.
Journal Article
62 (3 Sp. Iss. Sp. Iss. SI), pp. 345 - 349 (2005)
Identification of Helicobacter pylori surface proteins by selective proteinase K digestion and antibody phage display. Journal of Microbiological Methods 9.
Journal Article
72 (11), pp. 6546 - 6553 (2004)
Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa. Infection and Immunity 10.
Journal Article
72 (11), pp. 6738 - 6742 (2004)
Lack of stage-specific proteins in coccoid Helicobacter pylori cells. Infection and Immunity 11.
Journal Article
4 (10), pp. 2843 - 2848 (2004)
Helicobacter pylori vaccine development based on combined subproteome analysis. PROTEOMICS 12.
Journal Article
101 (23), pp. 8739 - 8744 (2004)
Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen. Proceedings of the National Academy of Sciences of the United States of America 13.
Journal Article
22 (17-18), pp. 2273 - 2277 (2004)
Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 14.
Journal Article
71 (11), pp. 6320 - 6328 (2003)
Autodisplay: Efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains. Infection and Immunity 15.
Journal Article
5 (12), pp. 1082 - 1095 (2003)
The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes and Infection 16.
Journal Article
5 (12), pp. 1082 - 1095 (2003)
The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes and Infection 17.
Journal Article
5 (12), pp. 1082 - 1095 (2003)
The RD1 proteins of Mycobacterium tuberculosis: expression in Mycobacterium smegmatis and biochemical characterization. Microbes and Infection 18.
Journal Article
552 (2-3), pp. 110 - 114 (2003)
Rapidly maturing red fluorescent protein variants with strongly enhanced brightness in bacteria. FEBS Letters 19.
Journal Article
37 (2-3), pp. 105 - 109 (2003)
T cell receptor-transgenic mouse models for studying cellular immune responses to Salmonella in vivo. FEMS Immunology and Medical Microbiology 20.
Journal Article
2 (1/2), pp. 88 - 92 (2003)
Helicobacter vaccine development based on global approaches. Genome Letters